Akebia Therapeutics (AKBA) EBT (2013 - 2026)
Akebia Therapeutics (AKBA) posted quarterly EBT of -$8.9 million for Q1 2026, down 246.07% year-over-year from $6.1 million in Q1 2025, and up 20.53% quarter-over-quarter from -$11.2 million in Q4 2025.
Akebia Therapeutics (AKBA) EBT (2013 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported EBT for 14 consecutive years, with -$8.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT fell 246.07% year-over-year to -$8.9 million; the TTM figure through Mar 2026 stood at -$18.8 million (up 58.6% YoY), while the FY2025 annual figure was -$3.7 million, up 94.64% from the prior year.
- EBT grew to -$8.9 million in Q1 2026 per AKBA's latest filing, from -$11.2 million in the prior quarter.
- Across five years, EBT topped out at $31.4 million in Q2 2022 and bottomed at -$62.3 million in Q1 2022.
- Historically, EBT has averaged -$13.0 million across 5 years, with a median of -$11.2 million in 2023.
- Annual changes were most pronounced in 2022 — EBT surged 138.24% — and 2024, when it tumbled 3814.01%.
- Akebia Therapeutics' EBT stood at -$4.1 million in 2022, then soared by 114.89% to $614000.0 in 2023, then sank by 3814.01% to -$22.8 million in 2024, then soared by 50.73% to -$11.2 million in 2025, then climbed by 20.53% to -$8.9 million in 2026.
- Business Quant data shows AKBA's EBT at -$8.9 million in Q1 2026, -$11.2 million in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Akebia Therapeutics | 240.57 Mn | 85.02 Mn | 38.70 Mn | -8.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.84 Mn |
| Mar 31, 2026 | -8.93 Mn |
| Dec 31, 2025 | -11.24 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 247,000.00 |
| Mar 31, 2025 | 6.11 Mn |
| Dec 31, 2024 | -22.80 Mn |
| Sep 30, 2024 | -20.04 Mn |
| Jun 30, 2024 | -8.58 Mn |
| Mar 31, 2024 | -17.99 Mn |
| Dec 31, 2023 | 614,000.00 |
| Sep 30, 2023 | -14.49 Mn |
| Jun 30, 2023 | -11.17 Mn |
| Mar 31, 2023 | -26.88 Mn |
| Dec 31, 2022 | -4.12 Mn |
| Sep 30, 2022 | -52.51 Mn |
| Jun 30, 2022 | 31.38 Mn |
| Mar 31, 2022 | -62.28 Mn |
| Dec 31, 2021 | -68.14 Mn |
| Sep 30, 2021 | -57.59 Mn |